What is the process of discovering new cancer drugs?
The process of discovering new cancer drugs involves several stages, including preclinical research, clinical trials, and regulatory approval. Initially, researchers identify potential drug targets through understanding the molecular and genetic basis of cancer. This is followed by the screening of compounds to find those that can interact with these targets effectively. Promising compounds undergo rigorous preclinical testing in the lab and in animal models to evaluate their safety and efficacy. If successful, these compounds move into clinical trials, which are conducted in multiple phases to further assess safety, dosage, and effectiveness in humans.
